Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Huzhou Sunflower Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Vasa Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Film Formers & Plasticizers
Lubricants & Glidants
Direct Compression
Coating Systems & Additives
Parenteral
Taste Masking
Co-Processed Excipients
Granulation
Topical
Thickeners and Stabilizers
Controlled & Modified Release
Emulsifying Agents
Solubilizers
Chewable & Orodispersible Aids
Soft Gelatin
Disintegrants & Superdisintegrants
API Stability Enhancers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
89
PharmaCompass offers a list of Pyridostigmine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pyridostigmine manufacturer or Pyridostigmine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pyridostigmine manufacturer or Pyridostigmine supplier.
PharmaCompass also assists you with knowing the Pyridostigmine API Price utilized in the formulation of products. Pyridostigmine API Price is not always fixed or binding as the Pyridostigmine Price is obtained through a variety of data sources. The Pyridostigmine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_RID_77069 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_RID_77069, including repackagers and relabelers. The FDA regulates DSSTox_RID_77069 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_RID_77069 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DSSTox_RID_77069 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DSSTox_RID_77069 supplier is an individual or a company that provides DSSTox_RID_77069 active pharmaceutical ingredient (API) or DSSTox_RID_77069 finished formulations upon request. The DSSTox_RID_77069 suppliers may include DSSTox_RID_77069 API manufacturers, exporters, distributors and traders.
click here to find a list of DSSTox_RID_77069 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A DSSTox_RID_77069 DMF (Drug Master File) is a document detailing the whole manufacturing process of DSSTox_RID_77069 active pharmaceutical ingredient (API) in detail. Different forms of DSSTox_RID_77069 DMFs exist exist since differing nations have different regulations, such as DSSTox_RID_77069 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A DSSTox_RID_77069 DMF submitted to regulatory agencies in the US is known as a USDMF. DSSTox_RID_77069 USDMF includes data on DSSTox_RID_77069's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DSSTox_RID_77069 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of DSSTox_RID_77069 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The DSSTox_RID_77069 Drug Master File in Japan (DSSTox_RID_77069 JDMF) empowers DSSTox_RID_77069 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the DSSTox_RID_77069 JDMF during the approval evaluation for pharmaceutical products. At the time of DSSTox_RID_77069 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of DSSTox_RID_77069 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a DSSTox_RID_77069 Drug Master File in Korea (DSSTox_RID_77069 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of DSSTox_RID_77069. The MFDS reviews the DSSTox_RID_77069 KDMF as part of the drug registration process and uses the information provided in the DSSTox_RID_77069 KDMF to evaluate the safety and efficacy of the drug.
After submitting a DSSTox_RID_77069 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their DSSTox_RID_77069 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of DSSTox_RID_77069 suppliers with KDMF on PharmaCompass.
A DSSTox_RID_77069 CEP of the European Pharmacopoeia monograph is often referred to as a DSSTox_RID_77069 Certificate of Suitability (COS). The purpose of a DSSTox_RID_77069 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of DSSTox_RID_77069 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of DSSTox_RID_77069 to their clients by showing that a DSSTox_RID_77069 CEP has been issued for it. The manufacturer submits a DSSTox_RID_77069 CEP (COS) as part of the market authorization procedure, and it takes on the role of a DSSTox_RID_77069 CEP holder for the record. Additionally, the data presented in the DSSTox_RID_77069 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the DSSTox_RID_77069 DMF.
A DSSTox_RID_77069 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. DSSTox_RID_77069 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of DSSTox_RID_77069 suppliers with CEP (COS) on PharmaCompass.
A DSSTox_RID_77069 written confirmation (DSSTox_RID_77069 WC) is an official document issued by a regulatory agency to a DSSTox_RID_77069 manufacturer, verifying that the manufacturing facility of a DSSTox_RID_77069 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting DSSTox_RID_77069 APIs or DSSTox_RID_77069 finished pharmaceutical products to another nation, regulatory agencies frequently require a DSSTox_RID_77069 WC (written confirmation) as part of the regulatory process.
click here to find a list of DSSTox_RID_77069 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing DSSTox_RID_77069 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for DSSTox_RID_77069 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture DSSTox_RID_77069 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain DSSTox_RID_77069 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a DSSTox_RID_77069 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of DSSTox_RID_77069 suppliers with NDC on PharmaCompass.
DSSTox_RID_77069 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DSSTox_RID_77069 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_RID_77069 GMP manufacturer or DSSTox_RID_77069 GMP API supplier for your needs.
A DSSTox_RID_77069 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_RID_77069's compliance with DSSTox_RID_77069 specifications and serves as a tool for batch-level quality control.
DSSTox_RID_77069 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_RID_77069 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DSSTox_RID_77069 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_RID_77069 EP), DSSTox_RID_77069 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_RID_77069 USP).
